Japanese Society for Palliative Medicine
News Letter No.61
Nov 2013  61
Journal Watch
東北大学大学院緩和ケア看護学分野  佐藤 一樹
(レビュー担当:宮下 光令、佐藤 一樹、清水 恵)



【N Engl J Med. 2013;368(23-26), 369(1-9)】

【Lancet. 2013;381(9881-5), 382(3886-94)】

【Lancet Oncol. 2013;14(7-9)】
緩和ケア普及のための地域プロジェクト(OPTIM study)の介入効果

Morita T, Miyashita M, Yamagishi A, Akiyama M, Akizuki N, Hirai K, Imura C, Kato M, Kizawa Y, Shirahige Y, Yamaguchi T, Eguchi K. Effects of a programme of interventions on regional comprehensive palliative care for patients with cancer: a mixed-methods study. Lancet Oncol. 2013;14(7):638-46.

Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721-32.

Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, Sklar CA, Robison LL, Diller L. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14(9):873-81.

【JAMA. 2013;309(21-4), 310(1-8)】

Simon NM. Treating complicated grief. JAMA. 2013;310(4):416-23.

【JAMA Intern Med. 2013;173(11-5)】

Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Landefeld CS, Chren MM. Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med. 2013;173(11):1006-12.

Balboni TA, Balboni M, Enzinger AC, Gallivan K, Paulk ME, Wright A, Steinhauser K, VanderWeele TJ, Prigerson HG. Provision of spiritual support to patients with advanced cancer by religious communities and associations with medical care at the end of life. JAMA Intern Med. 2013;173(12):1109-17.

Wachterman MW, Marcantonio ER, Davis RB, Cohen RA, Waikar SS, Phillips RS, McCarthy EP. Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists. JAMA Intern Med. 2013;173(13):1206-14.

【BMJ. 2013;346(7910-4), 347(7915-22)】

【BMJ Support Palliat Care. 2013;3(2)】

Billingham MJ, Billingham S-J. Congruence between preferred and actual place of death according to the presence of malignant or non-malignant disease: a systematic review and meta-analysis. BMJ Support Palliat Care. 2013;3(2):144-54.

学会や医療者による悪液質に関するweb サイトのレビュー
Mauri D, Tsiara A, Valachis A, Kalopita K, Tsali L, Tolis P, Polyzos NP. Cancer cachexia: global awareness and
guideline implementation on the web. BMJ Support Palliat Care. 2013;3(2):155-60.

Reid CM, Gibbins J, Bloor S, Burcombe M, McCoubrie R, Forbes K. Can the impact of an acute hospital end-of-life care tool on care and symptom burden be measured contemporaneously? BMJ Support Palliat Care. 2013;3(2):161-7.

Abel J, Pring A, Rich A, Malik T, Verne J. The impact of advance care planning of place of death, a hospice retrospective cohort study. BMJ Support Palliat Care. 2013;3(2):168-73.

Lind S, Adolfsson J, Axelsson B, Fürst CJ. Quality indicators for palliative and end of life care: a review of Swedish policy documents. BMJ Support Palliat Care. 2013;3(2):174-80.

スウェーデンの緩和ケアと終末期ケアのQI のレビュー
Thompson CA, Hugo SE, Swetz KM, Novotny PJ, Sloan JA, Loprinzi CL, Moynihan TJ, Shanafelt TD. End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care. BMJ Support Palliat Care. 2013;3(2):181-7.

ACP に焦点をあてた高齢者ケアの開発と評価
Silvester W, Parslow RA, Lewis VJ, Fullam RS, Sjanta R, Jackson L, White V, Hudson R. Development and evaluation of an aged care specifi c Advance Care Plan. BMJ Support Palliat Care. 2013;3(2):188-95.

英国の緩和ケア推進・普及プロジェクトの実践状況に関するWeb 調査
Paul S, Sallnow L. Public health approaches to end-of-life care in the UK: an online survey of palliative care services.
BMJ Support Palliat Care. 2013;3(2):196-9.

【Ann Intern Med. 2013;158(11-12), 159(1-4)】


【J Clin Oncol. 2013;31(16-24)】

Forsythe LP, Kent EE, Weaver KE, Buchanan N, Hawkins NA, Rodriguez JL, Ryerson AB, Rowland JH. Receipt of psychosocial care among cancer survivors in the United States. J Clin Oncol. 2013;31(16):1961-9.

Pietanza MC, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, Shouery M, Shaw M, Rogak LJ, Wilson M, Gabow A, Latif M, Lin KH, Wu Q, Kass SL, Miller CP, Tyson L, Sumner DK, Berkowitz-Hergianto A, Sima CS, Kris MG. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. J Clin Oncol. 2013;31(16):2004-9.

米国のAYA 世代がん患者のQOL の全国調査: AYA HOPE study
Smith AW, Bellizzi KM, Keegan TH, Zebrack B, Chen VW, Neale AV, Hamilton AS, Shnorhavorian M, Lynch CF.
Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study. J Clin Oncol. 2013;31(17):2136-45.

AYA 世代がん患者の心理的苦痛の推移:1 年間の縦断調査
Kwak M, Zebrack BJ, Meeske KA, Embry L, Aguilar C, Block R, Hayes-Lattin B, Li Y, Butler M, Cole S. Trajectories of psychological distress in adolescent and young adult patients with cancer: a 1-year longitudinal study. J Clin Oncol. 2013;31(17):2160-6.

静脈血栓塞栓症とその治療に関するASCO のガイドライン更新
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(17):2189-204.

Hawkes AL, Chambers SK, Pakenham KI, Patrao TA, Baade PD, Lynch BM, Aitken JF, Meng X, Courneya KS. Eff ects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J Clin Oncol. 2013;31(18):2313-21.

Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol. 2013;31(18):2322-36.

Bruera E, Yennurajalingam S, Palmer JL, Perez-Cruz PE, Frisbee-Hume S, Allo JA, Williams JL, Cohen MZ. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol. 2013;31(19):2421-7.

がん患者の妊孕性に関するASCO のガイドラインの更新
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K.Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-10.

米国医学研究所IOM による診療ガイドラインの開発基準を用いた最近のがん関連ガイドラインの評価
Reames BN, Krell RW, Ponto SN, Wong SL. Critical evaluation of oncology clinical practice guidelines. J Clin Oncol. 2013;31(20):2563-8.

Mack JW, Chen K, Boscoe FP, Gesten FC, Roohan PJ, Weeks JC, Schymura MJ, Schrag D. Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol. 2013;31(20):2569-79.

Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, Hudis CA, Scher HI, Sabattini P, Schrag D, Basch E. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-5.

術後補助化学療法を受ける乳がん患者での神経障害性疼痛に対するL- カルチニンの有効性、無作為化比較試験
Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL, 3rd, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol. 2013;31(20):2627-33.

Rathbone EJ, Brown JE, Marshall HC, Collinson M, Liversedge V, Murden GA, Cameron D, Bell R, Spensley S, Agrawal R, Jyothirmayi R, Chakraborti P, Yuille F, Coleman RE. Osteonecrosis of the Jaw and Oral Health-Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04). J Clin Oncol. 2013;31(21):2685-91.

診断後2-11 年の大腸がんサバイバーでの化学療法関連末梢神経障害とその関連要因
Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2- to 11-Year Colorectal Cancer Survivors: RESULTs From the Population-Based PROFILES Registry. J Clin Oncol. 2013;31(21):2699-707.

Administrative dataを用いたQOC 測定での患者の選好と治療適応の影響
Ryoo JJ, Ordin DL, Antonio AL, Oishi SM, Gould MK, Asch SM, Malin JL. Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol. 2013;31(21):2716-23.

がん診断後1 年間での不安と抑うつの推移とその予測因子(縦断調査)
Boyes AW, Girgis A, D'Este CA, Zucca AC, Lecathelinais C, Carey ML. Prevalence and predictors of the short-term trajectory of anxiety and depression in the fi rst year after a cancer diagnosis: a population-based longitudinal study. J Clin Oncol. 2013;31(21):2724-9.

根治不能肺がん患者での放射線治療の有効性に関する期待(The CanCORS study)
Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Expectations about the eff ectiveness of radiation therapy among patients with incurable lung cancer. J Clin Oncol. 2013;31(21):2730-5.

Lam WW, Chan M, Or A, Kwong A, Suen D, Fielding R. Reducing treatment decision confl ict diffi culties in breast cancer surgery: a randomized controlled trial. J Clin Oncol. 2013;31(23):2879-85.

Bylund Grenklo T, Kreicbergs UC, Valdimarsdottir UA, Nyberg T, Steineck G, Furst CJ. Communication and trust in the care provided to a dying parent: a nationwide study of cancer-bereaved youths. J Clin Oncol. 2013;31(23):2886-94.

【Ann Oncol. 2013;24(6-8)】
性的傾向(同性愛者かどうか)は、乳がんサバイバーのQOL に影響するか

Boehmer U, Glickman M, Winter M, Clark MA. Breast cancer survivors of different sexual orientations: which factors explain survivors' quality of life and adjustment? Ann Oncol. 2013;24(6):1622-30.

補助化学療法を受けた高齢がん患者のQOL に関する前向き研究
Park S, Kim IR, Baek KK, Lee SJ, Chang WJ, Maeng CH, Hong JY, Choi MK, Kim YS, Sun JM, Ahn JS, Park K, Jo J, Jung SH, Ahn MJ. Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer. Ann Oncol. 2013;24(6):1630-9.

Gamondi C, Pott M, Payne S. Families' experiences with patients who died after assisted suicide: a retrospective interview study in southern Switzerland. Ann Oncol. 2013;24(6):1639-44.


Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder WD, Filshie J, Ream E, Eaton D, Richardson A. A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupuncture. Ann Oncol. 2013;24(6):1645-52.

Goossens GA, Jerome M, Janssens C, Peetermans WE, Fieuws S, Moons P, Verschakelen J, Peerlinck K, Jacquemin M, Stas M. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol. 2013;24(7):1892-9.

ケアに対する満足度、社会的 背景との関連の検討

Bredart A, Kop JL, Griesser AC, Fiszer C, Zaman K, Panes-Ruedin B, Jeanneret W, Delaloye JF, Zimmers S, Berthet V, Dolbeault S. Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care. Ann Oncol. 2013;24(8):2151-8.

【Eur J Cancer. 2013;49(9-12)】

【Br J Cancer. 2013;108(11-12), 109(1-4)】
高齢がん患者のQOL アセスメント評価ツールEORTC QLQ-ELD14 の妥当性検討研究:多国間研究

Wheelwright S, Darlington AS, Fitzsimmons D, Fayers P, Arraras JI, Bonnetain F, Brain E, Bredart A, Chie WC, Giesinger J, Hammerlid E, O'Connor SJ, Oerlemans S, Pallis A, Reed M, Singhal N, Vassiliou V, Young T, Johnson C. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. Br J Cancer. 2013;109(4):852-8.

【Cancer. 2013;119(11-16)】
DNR の話し合いの際に患者の意思に任せるか、医師がDNRを勧めるかでの患者のDNR の選択の違い

Rhondali W, Perez-Cruz P, Hui D, Chisholm GB, Dalal S, Baile W, Chittenden E, Bruera E. Patient-physician communication about code status preferences: a randomized controlled trial. Cancer. 2013;119(11):2067-73.

入院後30 日以内に死亡するリスクのある患者を同定する予測モデル

Ramchandran KJ, Shega JW, Von Roenn J, Schumacher M, Szmuilowicz E, Rademaker A, Weitner BB, Loftus PD, Chu IM, Weitzman S. A predictive model to identify hospitalized cancer patients at risk for 30-day mortality based on admission criteria via the electronic medical record. Cancer. 2013;119(11):2074-80.

Ernst JC, Beierlein V, Romer G, Moller B, Koch U, Bergelt C. Use and need for psychosocial support in cancer patients: a population-based sample of patients with minor children. Cancer. 2013;119(12):2333-41.

治療の意思決定に患者自身がどう関わりたいかという選好と意思決定後のQOL の関連
Atherton PJ, Smith T, Singh JA, Huntington J, Diekmann BB, Huschka M, Sloan JA. The relation between cancer patient treatment decision-making roles and quality of life. Cancer. 2013;119(12):2342-9.